Clinical Trials Directory

Trials / Unknown

UnknownNCT04139421

Shinrin-Yoku (Forest Bathing) on Psychological Well-being

Effects of Shinrin-Yoku (Forest Bathing) on Psychological Well-being in Urban or Rural Green Space: A Pilot Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study will examine the effects of Shinrin-Yoku (forest bathing) as an intervention for enhancing psychological well-being in Chinese population. The main component of Shinrin-Yoku is the use of 5 senses in various activities, which typically includes forest walking, meditation, yoga etc. While Shinrin-Yoku has been widely recognized in Japan as a means of preventative health and stress management, it is still a new concept in some countries. In the existing literature, there is increasing evidence demonstrating the efficacy of Shinrin-Yoku for improving for health promotion. However, there is very limited research examining the effectiveness of Shinrin-Yoku in different types of natural environment and the sustainability of its effects.

Detailed description

This study will be a pilot randomized controlled trial on the effects of Shinrin-Yoku (forest bathing) as an intervention for enhancing psychological well-being in Chinese population. Prior to all study procedures, an online informed consent (with phone support) will be obtained from potential participants. Around 30 eligible participants will be randomly assigned to either the natural forest group or the urban green area group in a ratio of 1:1.

Conditions

Interventions

TypeNameDescription
BEHAVIORALShinrin-YokuShinrin-Yoku is a traditional Japanese practice of getting in touch with nature through walking in the forest in a relaxed way using all five senses.

Timeline

Start date
2019-11-01
Primary completion
2020-01-30
Completion
2020-03-30
First posted
2019-10-25
Last updated
2020-03-11

Locations

2 sites across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04139421. Inclusion in this directory is not an endorsement.